Millennium Management

Millennium Management Portfolio holdings

AUM $112B
1-Year Return 13.71%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Quarter Return
+4.58%
1 Year Return
+13.71%
3 Year Return
+41.74%
5 Year Return
+76.27%
10 Year Return
+245.84%
AUM
$71.4B
AUM Growth
-$6.31B
Cap. Flow
-$11.6B
Cap. Flow %
-16.27%
Top 10 Hldgs %
9.88%
Holding
5,398
New
1,163
Increased
1,425
Reduced
1,788
Closed
782

Sector Composition

1 Technology 17.5%
2 Healthcare 13.64%
3 Consumer Discretionary 11.41%
4 Financials 10.82%
5 Industrials 9.28%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AMGN icon
1476
Amgen
AMGN
$152B
$8.78M 0.01%
35,279
-158,445
-82% -$39.4M
KAIRU
1477
DELISTED
Kairos Acquisition Corp. Unit
KAIRU
$8.78M 0.01%
+876,650
New +$8.78M
ARKO icon
1478
ARKO Corp
ARKO
$585M
$8.76M 0.01%
+881,410
New +$8.76M
PSNL icon
1479
Personalis
PSNL
$541M
$8.76M 0.01%
355,989
+129,783
+57% +$3.19M
EBACU
1480
DELISTED
European Biotech Acquisition Corp. Units
EBACU
$8.76M 0.01%
+870,000
New +$8.76M
KNSA icon
1481
Kiniksa Pharmaceuticals
KNSA
$2.74B
$8.75M 0.01%
472,636
+222,242
+89% +$4.11M
SDACU
1482
DELISTED
Sustainable Development Acquisition I Corp. Unit
SDACU
$8.75M 0.01%
+879,200
New +$8.75M
TPIC
1483
DELISTED
TPI Composites
TPIC
$8.74M 0.01%
154,923
+29,266
+23% +$1.65M
MREO
1484
Mereo BioPharma
MREO
$290M
$8.73M 0.01%
2,589,367
+2,428,187
+1,507% +$8.18M
TIL icon
1485
Instil Bio
TIL
$161M
$8.72M 0.01%
+17,389
New +$8.72M
BGRY
1486
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$8.72M 0.01%
+860,043
New +$8.72M
LFTR
1487
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
$8.71M 0.01%
+885,510
New +$8.71M
PNFP icon
1488
Pinnacle Financial Partners
PNFP
$7.59B
$8.71M 0.01%
98,210
+60,746
+162% +$5.39M
TECX
1489
Tectonic Therapeutic, Inc. Common Stock
TECX
$337M
$8.71M 0.01%
57,174
-17,315
-23% -$2.64M
IDA icon
1490
Idacorp
IDA
$6.79B
$8.7M 0.01%
87,042
-27,323
-24% -$2.73M
JNK icon
1491
SPDR Bloomberg High Yield Bond ETF
JNK
$8.12B
$8.68M 0.01%
79,753
-29,480
-27% -$3.21M
IMCR icon
1492
Immunocore
IMCR
$1.84B
$8.67M 0.01%
+203,655
New +$8.67M
TRS icon
1493
TriMas Corp
TRS
$1.59B
$8.67M 0.01%
285,898
+270,842
+1,799% +$8.21M
PRTY
1494
DELISTED
Party City Holdco Inc.
PRTY
$8.67M 0.01%
1,494,401
-323,541
-18% -$1.88M
RLJ icon
1495
RLJ Lodging Trust
RLJ
$1.16B
$8.65M 0.01%
558,876
+495,698
+785% +$7.67M
ACRS icon
1496
Aclaris Therapeutics
ACRS
$213M
$8.65M 0.01%
343,247
+134,321
+64% +$3.38M
NSTB
1497
DELISTED
Northern Star Investment Corp. II
NSTB
$8.64M 0.01%
+864,145
New +$8.64M
LVOX
1498
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$8.64M 0.01%
858,819
-191,302
-18% -$1.92M
LOKM.U
1499
DELISTED
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
$8.64M 0.01%
+865,243
New +$8.64M
YMAB icon
1500
Y-mAbs Therapeutics
YMAB
$390M
$8.62M 0.01%
284,888
+179,831
+171% +$5.44M